User:Benjamin Elliott/Crystal Structure of the Bromodomain-PHD Finger Module of Human Transcriptional Co-Activator CBP in complex with Acetylated Histone 4 Peptide (H4K20ac)
From Proteopedia
(Difference between revisions)
| Line 10: | Line 10: | ||
== Relevance == | == Relevance == | ||
| - | Bromodomains have become a popular target for their role in human disease since they recognize the acetylation epigenetic tag. Potential drug targets for BrDs include inhibitors to aid in rheumatoid arthritis<ref>DOI 10.1038/nrd.2016.185</ref>, and certain types of cancer like squamous carcinoma<ref>DOI 10.1017/S1462399411001992>. | + | Bromodomains have become a popular target for their role in human disease since they recognize the acetylation epigenetic tag. Potential drug targets for BrDs include inhibitors to aid in rheumatoid arthritis<ref>DOI 10.1038/nrd.2016.185</ref>, and certain types of cancer like squamous carcinoma<ref>DOI 10.1017/S1462399411001992</ref>. |
== Structural highlights == | == Structural highlights == | ||
This protein is composed of two different domains -- the bromodomain (BrD) and the plant homeodomain (PHD) finger. In this particular module for human CBP, the two come together to form such interactions that they function as a single structural unit.There are two <scene name='76/769329/Zinc_ions/1'>zinc ion coordination centers</scene> that serve as a stable base for an extended interface established between the PHD finger and the BrD. The PHD finger itself has not shown to bind any specific peptide, whether in tandem or in its individual construct <ref> DOI 10.1016/j.febslet.2013.06.051</ref>. The separation of the domains is shown <scene name='76/769329/Annoying_one/2'>here</scene>, with the BrD shown in aquamarine, the PHD finger shown in red, and the linkers of the two domains shown in blue. | This protein is composed of two different domains -- the bromodomain (BrD) and the plant homeodomain (PHD) finger. In this particular module for human CBP, the two come together to form such interactions that they function as a single structural unit.There are two <scene name='76/769329/Zinc_ions/1'>zinc ion coordination centers</scene> that serve as a stable base for an extended interface established between the PHD finger and the BrD. The PHD finger itself has not shown to bind any specific peptide, whether in tandem or in its individual construct <ref> DOI 10.1016/j.febslet.2013.06.051</ref>. The separation of the domains is shown <scene name='76/769329/Annoying_one/2'>here</scene>, with the BrD shown in aquamarine, the PHD finger shown in red, and the linkers of the two domains shown in blue. | ||
Revision as of 03:12, 10 October 2017
4N3W at Resolution 1.9 Å
| |||||||||||
References
- ↑ Sanchez R, Meslamani J, Zhou MM. The bromodomain: from epigenome reader to druggable target. Biochim Biophys Acta. 2014 Aug;1839(8):676-85. doi: 10.1016/j.bbagrm.2014.03.011., Epub 2014 Mar 28. PMID:24686119 doi:http://dx.doi.org/10.1016/j.bbagrm.2014.03.011
- ↑ Filippakopoulos P, Picaud S, Mangos M, Keates T, Lambert JP, Barsyte-Lovejoy D, Felletar I, Volkmer R, Muller S, Pawson T, Gingras AC, Arrowsmith CH, Knapp S. Histone recognition and large-scale structural analysis of the human bromodomain family. Cell. 2012 Mar 30;149(1):214-31. PMID:22464331 doi:10.1016/j.cell.2012.02.013
- ↑ Plotnikov AN, Yang S, Zhou TJ, Rusinova E, Frasca A, Zhou MM. Structural Insights into Acetylated-Histone H4 Recognition by the Bromodomain-PHD Finger Module of Human Transcriptional Coactivator CBP. Structure. 2013 Dec 18. pii: S0969-2126(13)00437-1. doi:, 10.1016/j.str.2013.10.021. PMID:24361270 doi:http://dx.doi.org/10.1016/j.str.2013.10.021
- ↑ Giles RH, Peters DJ, Breuning MH. Conjunction dysfunction: CBP/p300 in human disease. Trends Genet. 1998 May;14(5):178-83. PMID:9613201
- ↑ Tough DF, Tak PP, Tarakhovsky A, Prinjha RK. Epigenetic drug discovery: breaking through the immune barrier. Nat Rev Drug Discov. 2016 Dec;15(12):835-853. doi: 10.1038/nrd.2016.185. Epub, 2016 Oct 21. PMID:27765940 doi:http://dx.doi.org/10.1038/nrd.2016.185
- ↑ Muller S, Filippakopoulos P, Knapp S. Bromodomains as therapeutic targets. Expert Rev Mol Med. 2011 Sep 13;13:e29. doi: 10.1017/S1462399411001992. PMID:21933453 doi:http://dx.doi.org/10.1017/S1462399411001992
- ↑ Park S, Martinez-Yamout MA, Dyson HJ, Wright PE. The CH2 domain of CBP/p300 is a novel zinc finger. FEBS Lett. 2013 Aug 19;587(16):2506-11. doi: 10.1016/j.febslet.2013.06.051. Epub , 2013 Jul 4. PMID:23831576 doi:http://dx.doi.org/10.1016/j.febslet.2013.06.051
